Sustained high transmission from ongoing U.S. outbreaks, fueled by pockets of low MMR vaccination coverage and imported cases from international travel, drives current trader sentiment on total measles cases through August 31. CDC data show 2,371 confirmed cases as of July 30, 2026—already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991—with activity reported across 45 states. Measles' extreme contagiousness, with a basic reproduction number of 12–18, allows rapid spread in under-vaccinated communities once introduced. Weekly CDC surveillance updates and any new state-level reports through late August remain the key near-term data releases that could shift market-implied odds, though model projections carry inherent uncertainty due to variable reporting lags and localized immunity levels.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti entro il 31 agosto?
Casi di morbillo negli Stati Uniti entro il 31 agosto?
NUOVO
31 ago 2026
2400+
99%
2450+
94%
2500+
86%
2550+
50%
2600+
59%
$983 Vol.
2400+
$512 Vol.
99%
2450+
$125 Vol.
94%
2500+
$306 Vol.
86%
2550+
$29 Vol.
50%
2600+
$10 Vol.
59%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained high transmission from ongoing U.S. outbreaks, fueled by pockets of low MMR vaccination coverage and imported cases from international travel, drives current trader sentiment on total measles cases through August 31. CDC data show 2,371 confirmed cases as of July 30, 2026—already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991—with activity reported across 45 states. Measles' extreme contagiousness, with a basic reproduction number of 12–18, allows rapid spread in under-vaccinated communities once introduced. Weekly CDC surveillance updates and any new state-level reports through late August remain the key near-term data releases that could shift market-implied odds, though model projections carry inherent uncertainty due to variable reporting lags and localized immunity levels.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Jul 31, 2026, 10:25 AM ET
Volume
$983Data di fine
31 ago 2026Mercato aperto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Sustained high transmission from ongoing U.S. outbreaks, fueled by pockets of low MMR vaccination coverage and imported cases from international travel, drives current trader sentiment on total measles cases through August 31. CDC data show 2,371 confirmed cases as of July 30, 2026—already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991—with activity reported across 45 states. Measles' extreme contagiousness, with a basic reproduction number of 12–18, allows rapid spread in under-vaccinated communities once introduced. Weekly CDC surveillance updates and any new state-level reports through late August remain the key near-term data releases that could shift market-implied odds, though model projections carry inherent uncertainty due to variable reporting lags and localized immunity levels.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$983Data di fine
31 ago 2026Mercato aperto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Sustained high transmission from ongoing U.S. outbreaks, fueled by pockets of low MMR vaccination coverage and imported cases from international travel, drives current trader sentiment on total measles cases through August 31. CDC data show 2,371 confirmed cases as of July 30, 2026—already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991—with activity reported across 45 states. Measles' extreme contagiousness, with a basic reproduction number of 12–18, allows rapid spread in under-vaccinated communities once introduced. Weekly CDC surveillance updates and any new state-level reports through late August remain the key near-term data releases that could shift market-implied odds, though model projections carry inherent uncertainty due to variable reporting lags and localized immunity levels.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti